Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 04:27:21 2024-12-05 EST			5-day change	1st Jan Change
10.94 ^GBX	+1.81%		-10.65%	-12.44%

12-04	IXICO plc, 2024 Earnings Call, Dec 04, 2024
12-04	IXICO plc Reports Earnings Results for the Full Year Ended September 30, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press	09-05	PU
IXICO : Appointment of CEO - Bram Goorden	08-05	PU
IXICO : to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial	05-23	PU
IXICO : Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai	23-07-12	PU
IXICO : Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET	23-04-03	PU
IXICO : AGM 2023 – Notice	22-12-16	PU
IXICO : Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease	22-12-12	PU
ANNUAL RESULTS: ANALYST PRESENTATION	22-12-09	PU
IXICO : ANNUAL REPORT 2022	22-12-06	PU
IXICO : New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease	22-09-21	PU
IXICO : INTERIM RESULTS ANALYST PRESENTATION	22-05-25	PU
IXICO : Contract award with a new client for a Huntington's Disease ('HD') trial worth circa £800,000	22-04-20	PU
CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research	22-03-21	PU
GAP-Net Site Optimization Conference 2022: Event Review	22-03-08	PU
IXICO & GAP Foundation: Alzheimer’s & The Bio-Hermes Study	22-03-02	PU
IXICO : Discover IXIQ.Ai \| IXICO's AI-Based Brain Segmentation Platform	22-02-18	PU
IXICO : Hails The Introduction of IXIQ.Ai, Its New Brain Imaging Technology	22-02-18	PU
IXICO : Engagement In Big Data Research Dementia Collaboration	22-01-25	PU
IXICO : AGM 2022 – Notice	21-12-17	PU
IXICO : Interview with IXICO & GAP foundation	21-12-06	PU
ANNUAL RESULTS: ANALYST PRESENTATION	21-12-06	PU
IXICO : ANNUAL REPORT 2021	21-12-06	PU
Phase III demyelinating disorder contract award with largest Pharma client worth >£1.0m	21-11-03	PU
Trading Update for year ended 30 September 2021	21-11-03	PU
“The team culture here is what makes us stand out” - Meet Ron Ramos, our Senior Director of Business Development	21-11-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Press Releases

Filters